(Q37148278)

18 August 2017

1 reference

title

Iron overload in hematopoietic cell transplantation (English)

1 reference

18 August 2017

1 reference

N S Majhail

1

1 reference

18 August 2017

H M Lazarus

series ordinal

2

1 reference

18 August 2017

L J Burns

series ordinal

3

1 reference

18 August 2017

language of work or name

English

0 references

publication date

28 April 2008

1 reference

Bone Marrow Transplantation

18 August 2017

published in

1 reference

18 August 2017

volume

41

1 reference

18 August 2017

issue

12

1 reference

18 August 2017

page(s)

997-1003

1 reference

https://scigraph.springernature.com/pub.10.1038/bmt.2008.99

18 August 2017

exact match

0 references

cites work

Transjugular biopsy of the liver in pediatric and adult patients using an 18-gauge automated core biopsy needle: a retrospective review of 410 consecutive procedures

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.99

Reversibility of cirrhosis in patients cured of thalassemia by bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.99

Balancing acts: molecular control of mammalian iron metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.99

7 January 2021

Disorders of iron metabolism

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.99

7 January 2021

Iron metabolism and toxicity

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.99

7 January 2021

Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.99

7 January 2021

The beta-thalassemias

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.99

7 January 2021

Complications of beta-thalassemia major in North America

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.99

7 January 2021

Efficacy of deferoxamine in preventing complications of iron overload in patients with thalassemia major

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.99

7 January 2021

Survival in medically treated patients with homozygous beta-thalassemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.99

7 January 2021

Longitudinal study of survival and causes of death in patients with thalassemia major in Greece

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.99

7 January 2021

Survival and causes of death in thalassaemia major

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.99

7 January 2021

Iron and infection: competition between host and microbes for a precious element

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.99

7 January 2021

Hepatic iron concentration and total body iron stores in thalassemia major.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.99

7 January 2021

Iron overload manifesting as apparent exacerbation of hepatic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.99

7 January 2021

Magnetic-susceptibility measurement of human iron stores

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.99

7 January 2021

Noninvasive measurement of iron: report of an NIDDK workshop

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.99

7 January 2021

Non-invasive assessment of hepatic iron stores by MRI.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.99

7 January 2021

Magnetic resonance imaging in the evaluation of iron overload in patients with beta thalassaemia and sickle cell disease

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.99

7 January 2021

Noninvasive measurement and imaging of liver iron concentrations using proton magnetic resonance.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.99

7 January 2021

MRI R2 and R2* mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patients

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.99

7 January 2021

Liver iron concentration evaluated by two magnetic methods: magnetic resonance imaging and magnetic susceptometry.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.99

7 January 2021

Hepatic iron stores and plasma ferritin concentration in patients with sickle cell anemia and thalassemia major

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.99

7 January 2021

Liver biopsy results in patients with sickle cell disease on chronic transfusions: poor correlation with ferritin levels

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.99

7 January 2021

Serum ferritin iron in iron overload and liver damage: correlation to body iron stores and diagnostic relevance

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.99

7 January 2021

Quantification by magnetic resonance imaging and liver consequences of post-transfusional iron overload alone in long term survivors after allogeneic hematopoietic stem cell transplantation (HSCT)

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.99

7 January 2021

A magnetic resonance imaging study of iron overload in hemopoietic stem cell transplant recipients with increased ferritin levels.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.99

7 January 2021

Nontransferrin-bound iron in serum of patients receiving bone marrow transplants

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.99

7 January 2021

Sequential changes in serum iron and ferritin in patients undergoing high-dose chemotherapy and radiation with autologous bone marrow transplantation: possible implications for treatment related toxicity

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.99

7 January 2021

Non-transferrin-bound iron during allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.99

7 January 2021

Rust and corrosion in hematopoietic stem cell transplantation: the problem of iron and oxidative stress

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.99

7 January 2021

Iron overload might increase transplant-related mortality in haematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.99

7 January 2021

Iron overload in bone marrow transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.99

7 January 2021

Autografting as a risk factor for persisting iron overload in long-term survivors of acute myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.99

7 January 2021

Role of non-transferrin bound iron in iron overload and liver dysfunction in long term survivors of acute leukaemia and bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.99

7 January 2021

Liver dysfunction in allogeneic bone marrow transplantation recipients.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.99

7 January 2021

Frequent severe liver iron overload after stem cell transplantation and its possible association with invasive aspergillosis

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.99

7 January 2021

Mucormycosis in allogeneic bone marrow transplant recipients: report of five cases and review of the role of iron overload in the pathogenesis

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.99

7 January 2021

Increased bone marrow iron stores is an independent risk factor for invasive aspergillosis in patients with high-risk hematologic malignancies and recipients of allogeneic hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.99

7 January 2021

Listeria Septicemia Complicating Bone Marrow Transplantation for Diamond-Blackfan Syndrome

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.99

7 January 2021

Iron overload is a major risk factor for severe infection after autologous stem cell transplantation: a study of 367 myeloma patients

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.99

7 January 2021

Serum Ferritin as Risk Factor for Veno-occlusive Disease of the Liver. Prospective Cohort Study

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.99

7 January 2021

Transfusional iron burden and liver toxicity after bone marrow transplantation for acute myelogenous leukemia and hemoglobinopathies.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.99

7 January 2021

Prognostic impact of elevated pretransplantation serum ferritin in patients undergoing myeloablative stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.99

7 January 2021

Effects of iron overload and hepatitis C virus positivity in determining progression of liver fibrosis in thalassemia following bone marrow transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.99

7 January 2021

Evaluation of cardiac status in iron-loaded thalassaemia patients following bone marrow transplantation: improvement in cardiac function during reduction in body iron burden

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.99

7 January 2021

Fate of iron stores in thalassaemia after bone-marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.99

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.99

7 January 2021

Early iron reduction programme for thalassaemia patients after bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.99

7 January 2021

Desferrioxamine therapy accelerates clearance of iron deposits after bone marrow transplantation for thalassaemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.99

7 January 2021

Iron removal with phlebotomy and recombinant human erythropoietin in secondary hemochromatosis after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.99

7 January 2021

Use of epoetin and darbepoetin in patients with cancer: 2007 American Society of Hematology/American Society of Clinical Oncology clinical practice guideline update

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.99

7 January 2021

EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer: 2006 update

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.99

7 January 2021

A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with beta-thalassemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.99

7 January 2021

A randomised comparison of deferasirox versus deferoxamine for the treatment of transfusional iron overload in sickle cell disease.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.99

7 January 2021

Identifiers

DOI

10.1038/BMT.2008.99

1 reference

18 August 2017

1 reference